A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs Response

被引：0
|
作者：
Papamichael, Konstantinos [1 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Harvard Med Sch, Div Gastroenterol, Dept Med, Ctr Inflammatory Bowel Dis, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷 / 12期
关键词：
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INFLIXIMAB; IBD;
D O I：
10.1038/ajg.2017.375
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1893 / 1894
页数：2
相关论文
共 50 条
  • [31] Editorial: therapeutic drug monitoring for anti-TNF agents-has it all been said?
    Domenech, E.
    Canete, F.
    Manosa, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (11-12) : 1113 - 1114
  • [32] IMMUNOGENICITY OF ANTI-TNF DRUGS AND CLINICAL RESPONSE IN PATIENTS WITH SPONDYLOARTHRITIS
    Geiger, D.
    Degboe, Y.
    Barnetche, T.
    Cantagrel, A.
    Ruyssen-Witrand, A.
    Constantin, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 343 - 343
  • [33] Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease
    Roblin, Xavier
    Riviere, Pauline
    Flamant, Mathurin
    Veyrard, Pauline
    Poullenot, Fabien
    Paul, S.
    Laharie, David
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 1904 - 1909
  • [34] Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?
    Roblin, Xavier
    Verot, Celine
    Paul, Stephane
    Duru, Gerard
    Williet, Nicolas
    Boschetti, Gilles
    Del Tedesco, Emilie
    Peyrin-Biroulet, Laurent
    Phelip, Jean Marc
    Nancey, Stephane
    Flourie, Bernard
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 2078 - 2085
  • [35] Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During Pregnancy
    Wieringa, Jantien W.
    Kruizinga, Matthijs D.
    Driessen, Gertjan J. A.
    van der Woude, C. Janneke
    Julsgaard, Mette
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (04): : 506 - 515
  • [36] Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques
    Bodini, Giorgia
    Demarzo, Maria Giulia
    Djahandideh, Afscin
    Ziola, Sebastiano
    Risso, Paolo
    Bertani, Lorenzo
    Baldissarro, Isabella
    Testa, Tommaso
    Marchi, Santino
    Savarino, Edoardo
    Giannini, Edoardo Giovanni
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (04) : 382 - 388
  • [37] Therapeutic drug monitoring of anti-tnf therapy in crohn's disease is mainly influenced by systemic inflammation
    Almenara de Riquer, Susana
    Egoavil Rojas, Cecilia
    Gutierrez, Ana
    Sempere, Laura
    Cameo Lorenzo, Jose Ignacio
    Gonzalez Navajas, Jose Manuel
    Frances, Ruben
    Zapater, Pedro
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 18 - 18
  • [38] Small Molecules as Anti-TNF Drugs
    Richmond, Victoria
    Michelini, Flavia M.
    Bueno, Carlos A.
    Alche, Laura E.
    Ramirez, Javier A.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (25) : 2920 - 2942
  • [39] Usual suspects: anti-TNF drugs
    Ahmet Mesut Onat
    Clinical Rheumatology, 2010, 29 : 447 - 448
  • [40] Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
    A. Nassar-Sheikh Rashid
    D. Schonenberg-Meinema
    S. C. Bergkamp
    S. Bakhlakh
    A. de Vries
    T. Rispens
    T. W. Kuijpers
    G. Wolbink
    J. M. van den Berg
    Pediatric Rheumatology, 19
12345